News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,950 Results
Type
Article (14278)
Company Profile (281)
Press Release (254391)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (79544)
Career Advice (153)
Deals (13231)
Drug Delivery (35)
Drug Development (50469)
Employer Resources (31)
FDA (5728)
Job Trends (5139)
News (144460)
Policy (10034)
Tag
Academia (915)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21681)
ALS (69)
Alzheimer's disease (851)
Antibody-drug conjugate (ADC) (108)
Approvals (5754)
Artificial intelligence (134)
Autoimmune disease (19)
Automation (5)
Bankruptcy (105)
Best Places to Work (4559)
BIOSECURE Act (6)
Biosimilars (44)
Biotechnology (232)
Bladder cancer (59)
Brain cancer (20)
Breast cancer (161)
Cancer (1525)
Cardiovascular disease (121)
Career advice (134)
Career pathing (2)
CAR-T (124)
Cell therapy (343)
Cervical cancer (9)
Clinical research (41180)
Collaboration (560)
Compensation (281)
Complete response letters (13)
COVID-19 (1034)
CRISPR (44)
C-suite (172)
Cystic fibrosis (78)
Data (1619)
Denatured (11)
Depression (32)
Diabetes (142)
Diagnostics (1303)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (86)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (92)
Earnings (30137)
Editorial (19)
Employer branding (4)
Employer resources (29)
Events (48807)
Executive appointments (477)
FDA (6502)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (518)
Gene editing (102)
Generative AI (10)
Gene therapy (266)
GLP-1 (372)
Government (1084)
Grass and pollen (2)
Guidances (70)
Healthcare (6595)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (100)
Indications (20)
Infectious disease (1101)
Inflammatory bowel disease (119)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (68)
Interviews (18)
IPO (7282)
IRA (11)
Job creations (863)
Job search strategy (127)
Kidney cancer (7)
Labor market (8)
Layoffs (215)
Leadership (3)
Legal (1386)
Liver cancer (34)
Lung cancer (207)
Lymphoma (103)
Machine learning (5)
Management (7)
Manufacturing (148)
MASH (63)
Medical device (2603)
Medtech (2604)
Mergers & acquisitions (6290)
Metabolic disorders (407)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (73)
Neuropsychiatric disorders (25)
Neuroscience (1279)
NextGen: Class of 2025 (2017)
Non-profit (852)
Now hiring (22)
Obesity (197)
Opinion (103)
Ovarian cancer (67)
Pain (45)
Pancreatic cancer (60)
Parkinson's disease (124)
Partnered (8)
Patents (137)
Patient recruitment (83)
Peanut (35)
People (25686)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14549)
Phase II (19162)
Phase III (12099)
Pipeline (947)
Policy (49)
Postmarket research (852)
Preclinical (6163)
Press Release (30)
Prostate cancer (64)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (299)
Real estate (1419)
Recruiting (12)
Regulatory (8678)
Reports (17)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (5)
RNA editing (5)
RSV (10)
Schizophrenia (64)
Series A (100)
Series B (70)
Service/supplier (1)
Sickle cell disease (41)
Special edition (12)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1977)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (12)
The Weekly (37)
Vaccines (217)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (73)
Last 7 days (634)
Last 30 days (1903)
Last 365 days (19324)
2025 (7126)
2024 (20551)
2023 (22415)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11739)
2017 (13746)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (43)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17354)
Australia (2945)
California (4084)
Canada (1180)
China (378)
Colorado (153)
Connecticut (156)
Delaware (110)
Europe (37349)
Florida (499)
Georgia (124)
Idaho (16)
Illinois (240)
India (10)
Indiana (94)
Iowa (2)
Japan (80)
Kansas (63)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (494)
Massachusetts (3255)
Michigan (74)
Minnesota (153)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (1012)
New Mexico (12)
New York (1093)
North Carolina (572)
North Dakota (5)
Northern California (1826)
Ohio (115)
Oklahoma (9)
Oregon (21)
Pennsylvania (772)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (5)
Southern California (1564)
Tennessee (25)
Texas (475)
United States (13946)
Utah (56)
Virginia (84)
Washington D.C. (31)
Washington State (362)
Wisconsin (17)
268,950 Results for "akari therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology
May 1, 2025
·
8 min read
Press Releases
Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
April 16, 2025
·
11 min read
Press Releases
Akari Therapeutics Releases Welcome Video from Newly Appointed Chief Executive Officer, Abizer Gaslightwala
April 22, 2025
·
5 min read
Press Releases
Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chief Executive Officer
March 20, 2025
·
8 min read
Press Releases
Akari Therapeutics Joins Webull Corporate Connect Service Platform
February 3, 2025
·
7 min read
Press Releases
Akari Therapeutics Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
February 19, 2025
·
6 min read
Press Releases
Akari Therapeutics Announces Successful Completion of Merger of Akari Therapeutics and Peak Bio
November 15, 2024
·
8 min read
Press Releases
Akari Therapeutics Announces Key Leadership Appointments
December 18, 2024
·
9 min read
Press Releases
Akari Therapeutics Regains Full Nasdaq Compliance
November 19, 2024
·
5 min read
Deals
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
Akari Therapeutics, Plc and Peak Bio Inc. announced completion of a joint portfolio prioritization review pursuant to which the combined entity, following completion of the previously announced merger of Akari and Peak, will focus on Peak’s ADC platform technology and Akari’s PAS-nomacopan Geographic Atrophy program.
May 1, 2024
·
16 min read
1 of 26,895
Next
